NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model

Area of Science:

• Neuroscience
• Endocrinology
• Stem Cell Biology

Background:

• Obesity management requires controlling food intake, with the hypothalamus's arcuate nucleus (ARC) as a key target.
• Neuropeptide FF (NPFF) shows anti-obesity potential in animal models by inhibiting Neuropeptide Y (NPY) neurons in the ARC.
• A lack of human-based models hinders understanding NPFF's precise action in human ARC neurons for pharmacological testing.

Purpose of the Study:

• To validate and utilize a human neural stem cell (hNSC)-derived ARC model for pharmacological studies.
• To investigate the effects of NPFF on cellular pathways and neuronal activity in human ARC neurons.
• To assess the therapeutic potential of NPFF and its receptor (NPFFR2) in obesity.

Main Methods:

• Development and validation of a human neural stem cell (hNSC)-based model representing the hypothalamic arcuate nucleus (ARC).
• Pharmacological testing of Neuropeptide FF (NPFF) effects on cellular pathways, specifically cAMP levels and cytoplasmic calcium oscillations.
• Assessment of neuronal activity in NPFF-treated human ARC neurons derived from hNSCs.

Main Results:

• NPFF significantly decreased cyclic adenosine monophosphate (cAMP) levels in human ARC neurons.
• This reduction in cAMP led to a decreased rate of cytoplasmic calcium oscillations, indicating neuronal inhibition.
• The study demonstrates NPFF's inhibitory effect on human ARC NPY neurons, supporting its anti-obesity potential.

Conclusions:

• Neuropeptide FF (NPFF) inhibits feeding behavior via action on human hypothalamic arcuate nucleus (ARC) NPY neurons.
• The human neural stem cell (hNSC)-derived ARC model is effective for pharmacological testing of human hypothalamic neurons.
• NPFF and its receptor NPFFR2 present a promising therapeutic target for obesity management.